Literature DB >> 31399902

Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.

Susanne Markendorf1, Dominik C Benz2, Michael Messerli2, Marvin Grossmann2, Andreas A Giannopoulos2, Dimitri Patriki2, Tobias A Fuchs2, Christoph Gräni2, Aju P Pazhenkottil2, Ronny R Buechel2, Philipp A Kaufmann2, Oliver Gaemperli2,3.   

Abstract

PURPOSE: A surface 12-lead electrocardiogram (ECG) is widely available, fast, inexpensive, and safe. However, its value to predict a true myocardial scar in patients with ischemic cardiomyopathy (ICM) has not been studied extensively yet. This study was conducted to assess whether Q waves on resting surface 12-lead ECG are predictive of non-viable myocardium in patients with ICM.
METHODS: We analyzed resting ECGs of 149 patients with ICM undergoing cardiac positron emission tomography (PET) with 13N-ammonia (NH3) and 18F-fluorodeoxyglucose (FDG) at our institution. Pathological Q waves and QS complexes were assigned to one of three coronary artery territories and compared to the PET findings. Myocardial scar was defined as 2 or more contiguous myocardial segments with an average (matched) reduction of NH3 and FDG uptake <50% of the maximum value.
RESULTS: Pathological Q waves had a sensitivity and specificity of 70% and 40%, respectively, and a PPV and NPV of 37% and 73%, respectively, to detect myocardial scar on FDG PET. For QS complexes, sensitivity and specificity were 46% and 59%, respectively, and PPV and NPV were 36% and 68%, respectively. Sensitivity was lower, but specificity was significantly higher in both the LCX and RCA compared to the LAD territory (p<0.001), particularly for QS complexes.
CONCLUSION: Pathological Q waves on resting 12-lead ECG have poor or at best moderate sensitivity and specificity to detect myocardial scar on FDG PET. These findings support the use of more advanced imaging techniques to assess myocardial viability in ICM.
© 2019. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Electrocardiogram; FDG PET; myocardial scar; myocardial viability

Mesh:

Substances:

Year:  2019        PMID: 31399902     DOI: 10.1007/s12350-019-01841-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  2 in total

1.  CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner.

Authors:  Pascal Koepfli; Thomas F Hany; Christophe A Wyss; Mehdi Namdar; Cyrill Burger; Alexander V Konstantinidis; Thomas Berthold; Gustav K Von Schulthess; Philipp A Kaufmann
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

2.  Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.

Authors:  Susanne Markendorf; Dominik C Benz; Michael Messerli; Marvin Grossmann; Andreas A Giannopoulos; Dimitri Patriki; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2019-08-09       Impact factor: 5.952

  2 in total
  5 in total

1.  Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting.

Authors:  Jiao Wang; Jian-Ming Li; Shuai Li; Bailing Hsu
Journal:  J Nucl Cardiol       Date:  2020-10-21       Impact factor: 3.872

2.  Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.

Authors:  Susanne Markendorf; Dominik C Benz; Michael Messerli; Marvin Grossmann; Andreas A Giannopoulos; Dimitri Patriki; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2019-08-09       Impact factor: 5.952

3.  Equilibrium radionuclide angiography: Present and future.

Authors:  Guillermo Romero-Farina; Santiago Aguadé-Bruix
Journal:  J Nucl Cardiol       Date:  2019-09-03       Impact factor: 5.952

4.  Evolving use of PET viability imaging.

Authors:  Juliana Brenande de Oliveira Brito; Robert A deKemp; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2021-01-01       Impact factor: 3.872

5.  Intravenous regular insulin is an efficient and safe procedure for obtaining high-quality cardiac 18F-FDG PET images: an open-label, single-center, randomized controlled prospective trial.

Authors:  Yang Chun Chen; Qing Qing Wang; Yue Hui Wang; Hui Lin Zhuo; Ruo Zhu Dai
Journal:  J Nucl Cardiol       Date:  2020-06-12       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.